Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies

Irreproducibility of preclinical findings could be a significant barrier to the “bench-to-bedside” development of oncolytic viruses (OVs). A contributing factor is the incomplete and non-transparent reporting of study methodology and design. Using the NIH Principles and Guidelines for Reporting Prec...

Descripción completa

Detalles Bibliográficos
Autores principales: Fergusson, Dean A., Wesch, Neil L., Leung, Garvin J., MacNeil, Jenna L., Conic, Isidora, Presseau, Justin, Cobey, Kelly D., Diallo, Jean-Simon, Auer, Rebecca, Kimmelman, Jonathan, Kekre, Natasha, El-Sayes, Nader, Krishnan, Ramya, Keller, Brian A., Ilkow, Carolina, Lalu, Manoj M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586991/
https://www.ncbi.nlm.nih.gov/pubmed/31276026
http://dx.doi.org/10.1016/j.omto.2019.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586991/
https://www.ncbi.nlm.nih.gov/pubmed/31276026
http://dx.doi.org/10.1016/j.omto.2019.05.004

Ejemplares similares